These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37727460)

  • 1. Optimization of Nasal Liposome Formulation of Venlafaxine Hydrochloride using a Box-Behnken Experimental Design.
    Khute S; Jangde RK
    Curr Ther Res Clin Exp; 2023; 99():100714. PubMed ID: 37727460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Khute S; Jangde RK
    Drug Dev Ind Pharm; 2024 Jan; 50(1):55-67. PubMed ID: 38112520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
    Soni PK; Saini TR
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
    Qiang F; Shin HJ; Lee BJ; Han HK
    Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies.
    Jazuli I; Annu ; Nabi B; Moolakkadath T; Alam T; Baboota S; Ali J
    J Pharm Sci; 2019 Sep; 108(9):3082-3090. PubMed ID: 31077685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical study of Doxorubicine-loaded liposomal drug delivery for the treatment of head and neck cancer: Optimization by Box-Behnken statistical design.
    Yang B
    Acta Biochim Pol; 2020 Jun; 67(2):149-155. PubMed ID: 32506868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures.
    Tulbah AS; Elkomy MH; Zaki RM; Eid HM; Eissa EM; Ali AA; Yassin HA; Aldosari BN; Naguib IA; Hassan AH
    Int J Pharm X; 2023 Dec; 6():100206. PubMed ID: 37637477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nose to brain delivery of naringin loaded transniosomes for epilepsy: formulation, characterisation, blood-brain distribution and invivo pharmacodynamic evaluation.
    Gupta I; Adin SN; Aqil M; Mujeeb M
    J Liposome Res; 2024 Mar; 34(1):60-76. PubMed ID: 37212622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel surface modified polymer-lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation.
    Pardeshi CV; Belgamwar VS; Tekade AR; Surana SJ
    J Mater Sci Mater Med; 2013 Sep; 24(9):2101-15. PubMed ID: 23728521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of Metoclopramide Hydrochloride-Loaded Lipid Carriers by QbD Approach for Combating Nausea: Safety and Bioavailability Evaluation in New Zealand Rabbit.
    Baranauskaite J; Aydin M; Uner B; Tas C
    AAPS PharmSciTech; 2024 Apr; 25(4):73. PubMed ID: 38575825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
    Jojo GM; Kuppusamy G; De A; Karri VVSNR
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and Characterization of Mucoadhesive Loratadine Nanoliposomes for Intranasal Administration.
    Tamaddon L; Mohamadi N; Bavarsad N
    Turk J Pharm Sci; 2021 Sep; 18(4):492-497. PubMed ID: 34496556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of valproic acid liposomes for delivery into the brain through an intranasal route.
    Jufri M; Yuwanda A; Surini S; Harahap Y
    Heliyon; 2022 Mar; 8(3):e09030. PubMed ID: 35284670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
    Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
    AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B; Khunt D; Misra M; Padh H
    Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Optimization of Liposome Containing Thermosensitive
    Mathure D; Sutar AD; Ranpise H; Pawar A; Awasthi R
    Assay Drug Dev Technol; 2023 Jan; 21(1):3-16. PubMed ID: 36576871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimization of Formulation and Process of Paclitaxel PEGylated Liposomes by Box-Behnken Response Surface Methodology].
    Shi YJ; Zhang XF; Guo QT
    Zhong Yao Cai; 2015 Dec; 38(12):2606-10. PubMed ID: 27352544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.